Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
8,153.70
+80.10
(+0.99%)
ASX 200
7,896.90
+77.30
(+0.99%)
AUD/USD
0.6526
-0.0010
(-0.15%)
OIL
82.62
+1.27
(+1.56%)
GOLD
2,235.60
+22.90
(+1.03%)
Bitcoin AUD
108,943.95
+2,747.90
(+2.59%)
FEELING THE PINCH?
Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now
Karyopharm Therapeutics Inc. (KPTI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5750
+0.0950
(+6.40%)
As of 11:39AM EDT. Market open.
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
146,033
146,033
157,074
209,819
108,085
Cost of revenue
4,942
4,942
5,213
3,402
2,705
Gross profit
141,091
141,091
151,861
206,417
105,380
Operating expenses
Research development
138,750
138,750
148,662
160,842
150,813
Selling general and administrative
131,881
131,881
145,401
143,846
126,417
Total operating expenses
270,631
270,631
294,063
304,688
277,230
Operating income or loss
-129,540
-129,540
-142,202
-98,271
-171,850
Interest expense
23,823
23,823
24,996
26,046
27,140
Total other income/expenses net
-356
-356
-83
-85
206
Income before tax
-142,776
-142,776
-164,922
-123,820
-195,964
Income tax expense
323
323
369
268
309
Income from continuing operations
-143,099
-143,099
-165,291
-124,088
-196,273
Net income
-143,099
-143,099
-165,291
-124,088
-196,273
Net income available to common shareholders
-143,099
-143,099
-165,291
-124,088
-196,273
Basic EPS
-1.31
-1.25
-2.02
-1.65
-2.72
Diluted EPS
-1.31
-1.25
-2.02
-1.65
-2.72
Basic average shares
108,031
114,221
81,871
75,218
72,044
Diluted average shares
108,031
114,221
81,871
75,218
72,044
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your privacy choices
About our ads
© 2024 Yahoo. All rights reserved.